The evolution and prospects of the gene expression profiling in colorectal cancer

Colorectal cancer (CRC) is a fatal disease and the third most common disease worldwide. The traditional staging system cannot accurately predict the outcome of the disease as CRC is highly heterogeneous at clonal and sub-clonal levels. The molecular studies offer a new avenue for providing treatment...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Clinical and Scientific Research 2023-10, Vol.12 (4), p.285-291
Main Authors: Srinivasamurthy, Banushree Chandrasekhar, Mathiyazhagan, Dharanya, Bhat, Ramachandra V.
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c1482-33dbc487d07e89e4b944481de124c8552b48a97f3c18d930038ef84f4bb927e13
container_end_page 291
container_issue 4
container_start_page 285
container_title Journal of Clinical and Scientific Research
container_volume 12
creator Srinivasamurthy, Banushree Chandrasekhar
Mathiyazhagan, Dharanya
Bhat, Ramachandra V.
description Colorectal cancer (CRC) is a fatal disease and the third most common disease worldwide. The traditional staging system cannot accurately predict the outcome of the disease as CRC is highly heterogeneous at clonal and sub-clonal levels. The molecular studies offer a new avenue for providing treatment and predicting the outcome of CRC. Several studies have been carried out to validate small to large signature genes that can predict the prognosis of CRC. The most commonly mutated genes in CRC include adenomatous polyposis coli (APC), TP53, KRAS and PIK3CA. The new challenge is translating the research outcome to clinical utility in patients of CRC. The coloprint, OncotypeDX, OncoDefender, ColoGuide Ex and ColoGuidePro are some of the proposed gene signatures available in CRC. In this study, we have reviewed the evolution and future prospects of proposed gene signature research published in PubMed indexed journals. The current article will provide an overview of the current developments in CRC.
doi_str_mv 10.4103/jcsr.jcsr_92_22
format article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_4103_jcsr_jcsr_92_22</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_4103_jcsr_jcsr_92_22</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1482-33dbc487d07e89e4b944481de124c8552b48a97f3c18d930038ef84f4bb927e13</originalsourceid><addsrcrecordid>eNpFkE1LAzEQhoMoWGrPXvMHts3XbpKjFL-gIEI9hyQ7qZF1sySr6L831YKXmYH3mWF4ELqmZC0o4Zs3X_L6WIxmhrEztGBMykbxVp6f5laS7hKtSomOiK6jumPdAj3vXwHDZxo-5phGbMceTzmVCfxccAp4rvEBxsp8TRnqcoUqEOIQxwOOI_ZpSLnSdsDejh7yFboIdiiwOvUlerm73W8fmt3T_eP2Ztd4KhRrOO-dF0r2RILSIJwWQijaA2XCq7ZlTiirZeCeql5zQriCoEQQzmkmgfIl2vzd9fXfkiGYKcd3m78NJeYoxfz6-JfCfwAAP1iH</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The evolution and prospects of the gene expression profiling in colorectal cancer</title><source>Medknow Open Access Medical Journals(OpenAccess)</source><creator>Srinivasamurthy, Banushree Chandrasekhar ; Mathiyazhagan, Dharanya ; Bhat, Ramachandra V.</creator><creatorcontrib>Srinivasamurthy, Banushree Chandrasekhar ; Mathiyazhagan, Dharanya ; Bhat, Ramachandra V.</creatorcontrib><description>Colorectal cancer (CRC) is a fatal disease and the third most common disease worldwide. The traditional staging system cannot accurately predict the outcome of the disease as CRC is highly heterogeneous at clonal and sub-clonal levels. The molecular studies offer a new avenue for providing treatment and predicting the outcome of CRC. Several studies have been carried out to validate small to large signature genes that can predict the prognosis of CRC. The most commonly mutated genes in CRC include adenomatous polyposis coli (APC), TP53, KRAS and PIK3CA. The new challenge is translating the research outcome to clinical utility in patients of CRC. The coloprint, OncotypeDX, OncoDefender, ColoGuide Ex and ColoGuidePro are some of the proposed gene signatures available in CRC. In this study, we have reviewed the evolution and future prospects of proposed gene signature research published in PubMed indexed journals. The current article will provide an overview of the current developments in CRC.</description><identifier>ISSN: 2277-5706</identifier><identifier>EISSN: 2277-8357</identifier><identifier>DOI: 10.4103/jcsr.jcsr_92_22</identifier><language>eng</language><ispartof>Journal of Clinical and Scientific Research, 2023-10, Vol.12 (4), p.285-291</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c1482-33dbc487d07e89e4b944481de124c8552b48a97f3c18d930038ef84f4bb927e13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Srinivasamurthy, Banushree Chandrasekhar</creatorcontrib><creatorcontrib>Mathiyazhagan, Dharanya</creatorcontrib><creatorcontrib>Bhat, Ramachandra V.</creatorcontrib><title>The evolution and prospects of the gene expression profiling in colorectal cancer</title><title>Journal of Clinical and Scientific Research</title><description>Colorectal cancer (CRC) is a fatal disease and the third most common disease worldwide. The traditional staging system cannot accurately predict the outcome of the disease as CRC is highly heterogeneous at clonal and sub-clonal levels. The molecular studies offer a new avenue for providing treatment and predicting the outcome of CRC. Several studies have been carried out to validate small to large signature genes that can predict the prognosis of CRC. The most commonly mutated genes in CRC include adenomatous polyposis coli (APC), TP53, KRAS and PIK3CA. The new challenge is translating the research outcome to clinical utility in patients of CRC. The coloprint, OncotypeDX, OncoDefender, ColoGuide Ex and ColoGuidePro are some of the proposed gene signatures available in CRC. In this study, we have reviewed the evolution and future prospects of proposed gene signature research published in PubMed indexed journals. The current article will provide an overview of the current developments in CRC.</description><issn>2277-5706</issn><issn>2277-8357</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpFkE1LAzEQhoMoWGrPXvMHts3XbpKjFL-gIEI9hyQ7qZF1sySr6L831YKXmYH3mWF4ELqmZC0o4Zs3X_L6WIxmhrEztGBMykbxVp6f5laS7hKtSomOiK6jumPdAj3vXwHDZxo-5phGbMceTzmVCfxccAp4rvEBxsp8TRnqcoUqEOIQxwOOI_ZpSLnSdsDejh7yFboIdiiwOvUlerm73W8fmt3T_eP2Ztd4KhRrOO-dF0r2RILSIJwWQijaA2XCq7ZlTiirZeCeql5zQriCoEQQzmkmgfIl2vzd9fXfkiGYKcd3m78NJeYoxfz6-JfCfwAAP1iH</recordid><startdate>202310</startdate><enddate>202310</enddate><creator>Srinivasamurthy, Banushree Chandrasekhar</creator><creator>Mathiyazhagan, Dharanya</creator><creator>Bhat, Ramachandra V.</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>202310</creationdate><title>The evolution and prospects of the gene expression profiling in colorectal cancer</title><author>Srinivasamurthy, Banushree Chandrasekhar ; Mathiyazhagan, Dharanya ; Bhat, Ramachandra V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1482-33dbc487d07e89e4b944481de124c8552b48a97f3c18d930038ef84f4bb927e13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Srinivasamurthy, Banushree Chandrasekhar</creatorcontrib><creatorcontrib>Mathiyazhagan, Dharanya</creatorcontrib><creatorcontrib>Bhat, Ramachandra V.</creatorcontrib><collection>CrossRef</collection><jtitle>Journal of Clinical and Scientific Research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Srinivasamurthy, Banushree Chandrasekhar</au><au>Mathiyazhagan, Dharanya</au><au>Bhat, Ramachandra V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The evolution and prospects of the gene expression profiling in colorectal cancer</atitle><jtitle>Journal of Clinical and Scientific Research</jtitle><date>2023-10</date><risdate>2023</risdate><volume>12</volume><issue>4</issue><spage>285</spage><epage>291</epage><pages>285-291</pages><issn>2277-5706</issn><eissn>2277-8357</eissn><abstract>Colorectal cancer (CRC) is a fatal disease and the third most common disease worldwide. The traditional staging system cannot accurately predict the outcome of the disease as CRC is highly heterogeneous at clonal and sub-clonal levels. The molecular studies offer a new avenue for providing treatment and predicting the outcome of CRC. Several studies have been carried out to validate small to large signature genes that can predict the prognosis of CRC. The most commonly mutated genes in CRC include adenomatous polyposis coli (APC), TP53, KRAS and PIK3CA. The new challenge is translating the research outcome to clinical utility in patients of CRC. The coloprint, OncotypeDX, OncoDefender, ColoGuide Ex and ColoGuidePro are some of the proposed gene signatures available in CRC. In this study, we have reviewed the evolution and future prospects of proposed gene signature research published in PubMed indexed journals. The current article will provide an overview of the current developments in CRC.</abstract><doi>10.4103/jcsr.jcsr_92_22</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2277-5706
ispartof Journal of Clinical and Scientific Research, 2023-10, Vol.12 (4), p.285-291
issn 2277-5706
2277-8357
language eng
recordid cdi_crossref_primary_10_4103_jcsr_jcsr_92_22
source Medknow Open Access Medical Journals(OpenAccess)
title The evolution and prospects of the gene expression profiling in colorectal cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T14%3A07%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20evolution%20and%20prospects%20of%20the%20gene%20expression%20profiling%20in%20colorectal%20cancer&rft.jtitle=Journal%20of%20Clinical%20and%20Scientific%20Research&rft.au=Srinivasamurthy,%20Banushree%20Chandrasekhar&rft.date=2023-10&rft.volume=12&rft.issue=4&rft.spage=285&rft.epage=291&rft.pages=285-291&rft.issn=2277-5706&rft.eissn=2277-8357&rft_id=info:doi/10.4103/jcsr.jcsr_92_22&rft_dat=%3Ccrossref%3E10_4103_jcsr_jcsr_92_22%3C/crossref%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1482-33dbc487d07e89e4b944481de124c8552b48a97f3c18d930038ef84f4bb927e13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true